Inventor
WATSON SIMON JAMES
GB18 patents
⚠️ This page may combine multiple inventors who share the name “WATSON SIMON JAMES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS AG
7 patentsUS7989497B2Aug 2, 2011
Squaramide derivatives as CXCR2 antagonist
NOVARTIS AG13 citations91
US7666878B2Feb 23, 2010
Pyrrolopyridine derivatives and their use as Crth2 antagonists
NOVARTIS AG16 citations91
US6921757B2Jul 26, 2005
Organic compounds
NOVARTIS AG34 citations90
US7745462B2Jun 29, 2010
Quinoline-2-one derivatives for the treatment of airways diseases
NOVARTIS AG7 citations71
US8791256B2Jul 29, 2014
Pyrrolopyridine derivatives and their use as CRTH2 antagonists
NOVARTIS AG1 citations61
US7723356B2May 25, 2010
Quinuclidine derivatives and their use as muscarinic m3 receptor antagonists
NOVARTIS AG3 citations60
US9169251B2Oct 27, 2015
Pyrrolopyridine derivatives and their use as CRTH2 antagonists
NOVARTIS AG0 citations51
BAETTIG URS
4 patentsUS8722925B2May 13, 2014
Squaramide derivatives as CXCR2 antagonist
BAETTIG URS13 citations91
US9115087B2Aug 25, 2015
Squaramide derivatives as CXCR2 antagonist
BAETTIG URS11 citations82
US8329754B2Dec 11, 2012
Squaramide derivatives as CXCR2 antagonist
BAETTIG URS11 citations82
US8288588B2Oct 16, 2012
Squaramide derivatives as CXCR2 antagonist
BAETTIG URS11 citations82
BELLENIE BENJAMIN RICHARD
3 patentsUS10112926B2Oct 30, 2018
Amino pyridine derivatives as phosphatidylinositol 3-kinase inhibitors
BELLENIE BENJAMIN RICHARD1 citations47
US9862711B2Jan 9, 2018
Pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
BELLENIE BENJAMIN RICHARD1 citations47
US10004732B2Jun 26, 2018
Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
BELLENIE BENJAMIN RICHARD0 citations36